References
O’Donnel JM, Shelton RC (2011) Drug therapy of depression and anxiety disorders. In: Brunton L, Chaner B, Knollman B (eds) Goodman and Gilman’s the pharmacological basis of therapeutics, 12th edn. Mc Graw Hill, New York, pp 398–415
European Medicines Agency. Cymbalta. http://www.theodora.com/drugs/eu/cymbalta.html
Andrade C, Sharma E (2016) Serotonin reuptake inhibitors and risk of abnormal bleeding. Psychiatr Clin North Am 39:413–426
Maschino F, Hurault-Delarue C, Chebbane L, Fabry V, Montastruc JL, Bagheri H (2012) French Association of Regional Pharmacovigilance Centers. Bleeding adverse drug reactions (ADRs) in patients exposed to antiplatelet plus serotonin reuptake inhibitor drugs: analysis of the French Spontaneous Reporting Database for a controversial ADR. Eur J Clin Pharmacol 68:1557–1560
Halperin D, Reber G (2007) Influence of antidepressants on hemostasis. Dialogues Clin Neurosci 9:47–59
Miremont-Salamé G, Théophile H, Haramburu F, Bégaud B (2016) Causality assessment in pharmacovigilance: the French method and its successive updates. Therapie 71:179–186
Bate A, Lindquist M, Edwards IR (2008) The application of knowledge discovery in databases to post-marketing drug safety: example of the WHO database. Fundam Clin Pharmacol 22:127–140
Balhara Y, Sagar R, Varghese ST (2007) Bleeding gums: duloxetine may be the cause. J Postgrad Med 53:44–45
Yavasoglu I, Kadikoylu G, Bolaman Z (2008) Gingival bleeding due to venlafaxine. Ann Pharmacother 42:144–145
Borrás-Blasco J, Marco-Garbayo JL, Bosca-Sanleon B, Navarro-Ruiz A (2002) Probable interaction between citalopram and acenocoumarol. Ann Pharmacother 36:345
Friedlander AH, Mahler ME (2001) Major depressive disorder. Psychopathology, medical management and dental implications. J Am Dent Assoc 132:629–638
Acknowledgements
The authors would like to acknowledge the Uppsala Monitoring Center (UMC) which provided and gave permission to use the data analyzed in the present study. The authors also thank the French Network of Pharmacovigilance Centers that contributed to the data. They also wish to thank the French Drug Agency (Agence Nationale de Sécurité du Médicament, ANSM) for the use of the French PharmacoVigilance DataBase. The content of this article only involved its authors and the opinions and conclusions are not necessarily those of WHO UMC or ANSM. The authors of this article are solely responsible for the conclusions.
Author information
Authors and Affiliations
Contributions
Celine Gicquel, François Montastruc, and Jean-Louis Montastruc designed the study, analyzed the data, performed the analysis, and wrote the manuscript. Celine Gicquel, Chouki Chenaf, Aurore Gouraud, Milou Drici, and Emmanuelle Bondon-Guitton extracted the data. All the authors corrected and approved the manuscript.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Financial support
The work was performed during the university research time of the authors using the databases which are available without fees in the department of the authors.
Rights and permissions
About this article
Cite this article
Gicquel, C., Moulis, F., Chenaf, C. et al. Duloxetine and gingival bleeding: a case-report and reviews of the French and World PharmacoVigilance Databases and literature. Eur J Clin Pharmacol 73, 1197–1198 (2017). https://doi.org/10.1007/s00228-017-2290-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00228-017-2290-7